Over the past couple of years, FDA-regulated industries such as the medical devices industry have witnessed a myriad of changes. The advent of value-based reimbursement models and accountable care has resulted in a seismic shift in the way top medical device companies...
Market Intelligence Study on the Dry Chemistry Analyzer (DCA) for Point of Care Testing (POCT)
In recent years, healthcare has become more consumer-focused, and there is a significant demand for the development and adoption of convenient screen tests for disease diagnosis. Despite unfavorable economic conditions, governments across the globe are focusing on...